Moderna had designs on releasing a combined influenza and covid-19 vaccine after some promising trials, but this week the ...

After discussions with the FDA, Moderna has withdrawn its application for a combination shot, which had demonstrated efficacy ...

The announcement, which followed the FDA setting new guidelines on COVID vaccine approvals, erased the stock’s gains from ...